Gustafsson et al. [94] suggested that maternal serum levels of IL-6, TNF-α, and monocyte chemoattractant protein-1 (MCP-1) are possible markers of ADHD risk, which is the first human study providing evidence of an association between inflammation and brain developmental/behavioral defects. This evidence concerns the gene CCL2 and attention deficit-hyperactivity disorder.